US EditionIf Europe wants to compete, the Biotech Act must deliver
4 Articles
4 Articles
Pharma Deutschland e.V. [Newsroom]Berlin (ots) - Pharma Deutschland welcomes today's publication of the draft of Part 1 of the European Biotech Act by the European Commission. The proposals for a revision of the legal framework provide important impulses for ... Continue reading here...Original content of: Pharma Deutschland e.V., transmitted by news aktuell
European Biotech Act: New initiative to mobilize €10 billion investment for Europe's biotech sector
Biotech can revolutionize healthcare, by delivering ground-breaking medicines and treatments to patients, such as AI-driven cardiac sensors to monitor for heart failure, mRNA therapies or monoclonal antibodies to help the immune system to spot harmful cells quickly. It is at the core of pioneering work in gene therapies, personalized medicine and biopharmaceuticals, such as synthetic insulin.This initiative — BioTechEU — will be part of the EIB …
'Missed Opportunity': EU Biotech Act Excludes Novel Foods from Regulatory Sandboxes
6 Mins Read The EU’s first Biotech Act has proposed to expand the support given to companies looking for novel food approval, but has kept these products out of the scope of regulatory sandboxes. Despite promising a regulatory overhaul for novel foods like cultivated meat, the provisions in the European Union’s newly released Biotech Act are half-baked. The much-anticipated strategy seeks to boost the region’s competitiveness in biotechnology by…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
